Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

Baxter International Inc. (NYSE:BAX), a global leader in medical technology, announced today the immediate retirement of José ...

Baxter International seems pretty uncompelling as ... In particular, the previous quarter was a pretty large miss. So, if I was to key in on any of these, I’d particularly be looking at how ...

Deerfield-based Baxter International announced Monday that its ... but Almeida said in the release, “With the key elements of our broad strategic transformation complete, this is the right ...

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...

Baxter International (BAX ... to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Baxter International's CEO, president and chair, José "Joe" Almeida, abruptly retired from the medtech company Feb. 3 after nine years at the helm. Mr. Almeida assumed the roles in January 2016 ...

Baxter International’s longtime CEO and board ... count on us every year,” Almeida said in a statement. “With the key elements of our broad strategic transformation complete, this is the ...

On the heels of a major companywide restructuring, Baxter International told investors ... an exercise Almeida said Baxter does every year, is key to keeping the company profitable.

Baxter International announced Monday that its CEO ... but Almeida said in the release, “With the key elements of our broad strategic transformation complete, this is the right time for a ...